Skip to main content
ESE
NYSE Manufacturing

ESCO Posts Record FY2026 Results, Guides FY2027 Sales to $2.05-$2.09B on Megger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$223.86
Mkt Cap
$6.915B
52W Low
$193.68
52W High
$362.15
52W Position info
16% above low
Off High info
38% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ESE sits 16% above its 52-week low of $193.68.

Summary

ESCO reported record FY2026 results — sales up 21% to $1.32B, Adjusted EPS up 40% to $8.42 and backlog of $1.55B — and guided FY2027 sales to $2.05-$2.09B and Adjusted EPS to $9.40-$9.70 as Megger consolidates.


Key Events · Earnings and Guidance · ESE

  • Record FY2026 Results

    FY2026 sales rose 21% to $1.322B, GAAP EPS from continuing operations rose 25% to $5.63 and Adjusted EPS rose 40% to $8.42; Q4 sales grew 9% to $384M and Q4 Adjusted EPS rose 15% to $2.67.

  • FY2027 Guidance Includes Megger

    Management guides FY2027 sales to $2.05-$2.09B (55-58% growth), including $640-$660M from Megger, and Adjusted EPS to $9.40-$9.70 (12-15% growth) with Adjusted EBIT margins of 21.2-21.8%.

  • Record Backlog and Orders

    FY2026 entered orders rose 11% to $1.737B (book-to-bill 1.31x) and year-end backlog reached a record $1.549B; Q4 entered orders rose 22% to $392M.

  • Cash Flow and Balance Sheet

    Operating cash flow from continuing operations was $296M for FY2026, up $95M, while long-term debt fell to $14M from $166M at September 30, 2025.


Analysis · ESE · Manufacturing

ESCO closed fiscal 2026 with record orders, sales and backlog, and the Megger acquisition that closed October 1 now drives the FY2027 outlook: sales are guided 55-58% higher to $2.05-$2.09B, with $640-$660M of that from Megger. Adjusted EPS is guided to $9.40-$9.70, only 12-15% growth because interest expense jumps to $61-$63M and margins dilute to 21.2-21.8% as the lower-margin Megger revenue folds in. The core business is still growing: Q4 organic sales rose 9% and Q4 orders rose 22%, and FY2026 operating cash flow of $296M gives the company room to pay down the debt taken on for the deal. The main question for holders is whether Megger integration and the planned cost cuts can lift margins back toward the legacy business over time.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ESE was trading at $223.86 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.9B. The 52-week trading range was $193.68 to $362.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESE - Latest Insights

ESE
Nov 19, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $223.86
Real-time Price: $234.71 info
Change: +$10.85 (+5%) info
Market Cap: $6.915B info
ESE
Oct 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $274.95
Real-time Price: $234.71 info
Change: -$40.24 (-15%) info
Market Cap: $6.915B info
ESE
Oct 01, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $269.92
Real-time Price: $234.71 info
Change: -$35.21 (-13%) info
Market Cap: $6.915B info
ESE
Aug 10, 2026, 1:56 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $301.67
Real-time Price: $234.71 info
Change: -$66.96 (-22%) info
Market Cap: $6.915B info
ESE
Jun 03, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $295.43
Real-time Price: $234.71 info
Change: -$60.72 (-21%) info
Market Cap: $6.915B info